The global Drug Discovery Services Market , valued at US$14.89 billion in 2024, is forecasted to grow at a robust CAGR of ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational drug discovery, with proprietary, proteome-wide SAR delivering ...

Building the world’s largest biobank with data from global populations to accelerate biomarker and drug discovery and development of ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

The drug discovery pact between Charles River Laboratories, Valo Health and Flagship Pioneering is starting to bear fruit. | The drug discovery pact between Charles River Laboratories, Valo Health and ...

Learn how drug absorption and predictive modeling drive advancements in pharmaceuticals and precision medicine.

During a health-focused event in New York on Tuesday, Google announced that it’s developing a collection of “open” AI models for drug discovery ... “The development of therapeutic drugs ...

Nature spoke to a number of researchers who are active in this field, in an effort to tease out some of the actions that could be taken to enable AI to transform drug discovery and development to ...